Skip to main navigation Skip to search Skip to main content

Secukinumab provides sustained improvements in the signs and symptoms of active psoriatic arthritis: 3-year efficacy and safety results from phase 3 future 1 trial

  • Philip J. Mease
  • , Arthur Kavanaugh
  • , Andreas Reimold
  • , Hasan Tahir
  • , Juergen Rech
  • , Stephen Hall
  • , Piet P.M.M. Geusens
  • , Pellet Pascale
  • , Evie Marie Delicha
  • , Luminata Pricop
  • , Shepard Mpofu

Research output: Contribution to journal › Article › peer-review

Original languageAmerican English
JournalDefault journal
StatePublished - Jan 1 2017

Disciplines

  • Alternative and Complementary Medicine
  • Medicine and Health Sciences

Cite this